Cartesian Therapeutics
RNAC
#6732
Rank
C$0.65 B
Marketcap
$27.38
Share price
3.61%
Change (1 day)
-39.30%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -C$0.33 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are C$54.1 Million. In 2023 the company made an earning of -C$0.33 Billion a decrease over its 2022 earnings that were of C$52.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.33 Billion0.96%
2023 -C$0.33 Billion-724%
2022 C$52.27 M-649.67%
2021 -C$9.52 Million-89.78%
2020 -C$93.11 Million25.06%
2019 -C$74.45 Million-15.68%
2018 -C$88.3 Million-0.43%
2017 -C$88.68 Million83.41%
2016 -C$48.35 Million44.3%
2015 -C$33.51 Million